Market closed
ReShape Lifesciences Inc./$RSLS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
Ticker
$RSLS
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
18
Website
RSLS Metrics
BasicAdvanced
$4.5M
-
-$13.83
1.92
-
Price and volume
Market cap
$4.5M
Beta
1.92
52-week high
$3.05
52-week low
$0.30
Average daily volume
24M
Financial strength
Current ratio
0.92
Quick ratio
0.337
Long term debt to equity
-16.206
Total debt to equity
-382.213
Management effectiveness
Return on assets (TTM)
-53.93%
Return on equity (TTM)
-222.46%
Valuation
Price to revenue (TTM)
0.025
Price to book
-1.14
Price to tangible book (TTM)
-1.14
Price to free cash flow (TTM)
-0.046
Growth
Revenue change (TTM)
-7.74%
Earnings per share change (TTM)
-87.53%
3-year revenue growth (CAGR)
-16.19%
RSLS News
AllArticlesVideos
ReShape Lifesciences Inc. (RSLS) Earnings Highlights and Strategic Business Update Conference (Transcript)
Seeking Alpha·5 days ago
ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market
GlobeNewsWire·7 days ago
ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update
GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for ReShape Lifesciences Inc. stock?
ReShape Lifesciences Inc. (RSLS) has a market cap of $4.5M as of April 16, 2025.
What is the P/E ratio for ReShape Lifesciences Inc. stock?
The price to earnings (P/E) ratio for ReShape Lifesciences Inc. (RSLS) stock is 0 as of April 16, 2025.
Does ReShape Lifesciences Inc. stock pay dividends?
No, ReShape Lifesciences Inc. (RSLS) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next ReShape Lifesciences Inc. dividend payment date?
ReShape Lifesciences Inc. (RSLS) stock does not pay dividends to its shareholders.
What is the beta indicator for ReShape Lifesciences Inc.?
ReShape Lifesciences Inc. (RSLS) has a beta rating of 1.92. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.